Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure
- 1 June 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 59 (6) , 2222-2232
- https://doi.org/10.1046/j.1523-1755.2001.00737.x
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbitAtherosclerosis, 2000
- Antiinflammatory properties of mycophenolate mofetil in murine endotoxemia: inhibition of TNF-α and upregulation of IL-10 releaseInternational Journal of Immunopharmacology, 1999
- Angiotensin II Activates the Proinflammatory Transcription Factor Nuclear Factor-κB in Human MonocytesBiochemical and Biophysical Research Communications, 1999
- Angiotensin-Converting Enzyme Is Upregulated in the Proximal Tubules of Rats With Intense ProteinuriaHypertension, 1999
- Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II–Induced HypertensionHypertension, 1999
- Oxidative Stress in the Dahl Hypertensive RatHypertension, 1997
- Renal Accumulation of Circulating Angiotensin II in Angiotensin II–Infused RatsHypertension, 1996
- Osteopontin expression in angiotensin II-induced tubulointerstitial nephritisKidney International, 1994
- Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.Hypertension, 1992
- Renal injury from angiotensin II-mediated hypertension.Hypertension, 1992